Company Description
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.
It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.
In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents.
Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
| Country | United States |
| Founded | 2003 |
| IPO Date | Aug 3, 2012 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 5,000 |
| CEO | Daniel Scavilla |
Contact Details
Address: 2560 General Armistead Avenue Audubon, Pennsylvania 19403 United States | |
| Phone | 610 930 1800 |
| Website | globusmedical.com |
Stock Details
| Ticker Symbol | GMED |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001237831 |
| CUSIP Number | 379577208 |
| ISIN Number | US3795772082 |
| Employer ID | 04-3744954 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Daniel T. Scavilla | President, Chief Executive Officer and Director |
| David C. Paul | Co-Founder and Executive Chairman |
| Keith W. Pfeil | Chief Financial Officer and Chief Operating Officer |
| Kelly G. Huller Esq. | Senior Vice President, General Counsel and Secretary |
| Brian J. Kearns | Senior Vice President of Business Development and Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 2, 2024 | 144 | Filing |
| Nov 21, 2024 | 144 | Filing |
| Nov 21, 2024 | 144 | Filing |
| Nov 21, 2024 | 144 | Filing |
| Nov 21, 2024 | 144 | Filing |
| Nov 21, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 6, 2024 | 144 | Filing |
| Nov 6, 2024 | 144 | Filing |
| Nov 5, 2024 | 10-Q | Quarterly Report |